Key summary points
To translate and culturally adapt the SarQoL® questionnaire into Lithuanian language and investigate its main psychometric properties.
AbstractSection FindingsThe total score of the SarQoL® questionnaire was significantly lower for sarcopenic subjects compared to non-sarcopenic subjects. Cronbach’s alpha coefficient was 0.95. The SarQoL® questionnaire revealed good construct validity and test–retest reliability.
AbstractSection MessageLithuanian version of the SarQoL® can be used to assess quality of life in sarcopenic population.
Abstract
Purpose
The aim of this study was to translate and culturally adapt the SarQoL® questionnaire into Lithuanian and investigate its main psychometric properties.
Methods
A cross-sectional study was performed on community-dwelling Lithuanian people aged ≥ 60 years. The revised criteria of the European Working Group on Sarcopenia in Older People were used. A forward–backward methodology was used for the translation, with a pre-test of the final version of the Lithuanian SarQoL® questionnaire. Adjusted logistic regression analysis was used to compare sarcopenic and non-sarcopenic subjects. Internal consistency was determined using Cronbach’s alpha coefficient. The correlation of total score of the SarQoL® and each domain of the Short-form General Health Survey (SF-36) and EuroQol-5D (EQ-5D) questionnaires was measured using Spearman’s correlations. Test–retest reliability was measured by the intraclass correlation coefficient.
Results
The study was performed on 176 subjects. Fifty-eight subjects were diagnosed with sarcopenia. After adjustment for confounders, the total score of the SarQoL® questionnaire was significantly lower for sarcopenic subjects compared to non-sarcopenic subjects (50.32 ± 8.58 vs 73.75 ± 13.51, p < 0.001). Cronbach’s alpha coefficient was 0.95. Neither floor nor ceiling effects were found. The SarQoL® questionnaire revealed good correlation with similar domains of the SF-36 and EQ-5D questionnaires for convergent validity and weak correlations with different domains for divergent validity, confirming its construct validity. An excellent agreement between test and retest was found with an ICC of 0.976 (95% CI 0.959–0.986).
Conclusions
Lithuanian version of the SarQoL® is valid, reliable and consistent and could be used to assess quality of life in sarcopenic population.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R (2017) Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord 16:21
Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12:e0169548
Zhang X, Zhang W, Wang C, Tao W, Dou Q, Yang Y (2018) Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis. BMC Geriatr 18:188
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31
Tsekoura M, Kastrinis A, Katsoulaki M, Billis E, Gliatis J (2017) Sarcopenia and its impact on quality of life. In: Vlamos P (ed) GeNeDis 2016. Springer, Berlin, pp 213–218
Higginson IJ, Carr AJ (2001) Using quality of life measures in the clinical setting. Br Med J 322:1297–1300
Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC et al (2013) Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 42:378–384
Go SW, Cha YH, Lee JA, Park HS (2013) Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med 34:281–288
Rabin R, de Charro F (2001) EQ-SD: a measure of health status from the EuroQol Group. Ann Med 33:337–343
Ware JEJ, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483
Beaudart C, Biver E, Reginster J-Y, Rizzoli R, Rolland Y, Bautmans I et al (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44:960–966
Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935
Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS) AU. Clin Gerontol 5:165–173
Gould H, Brennan SL, Kotowicz MA, Nicholson GC, Pasco JA (2014) Total and appendicular lean mass reference ranges for Australian men and women: the Geelong Osteoporosis Study. Calcif Tissue Int 94:363–372
Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40:423–429
Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM et al (2014) Grip strength across the life course: normative data from twelve British studies. PLoS ONE 9:e113637–e113637
Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV et al (2000) Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol Ser A 55:M221–M231
Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191
Beaudart C, Edwards M, Moss C, Reginster J-Y, Moon R, Parsons C et al (2017) English translation and validation of the SarQoL(®), a quality of life questionnaire specific for sarcopenia. Age Ageing 46:271–276
Beaudart C, Biver E, Reginster J, Rizzoli R, Rolland Y, Bautmans I et al (2017) Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle 8:238–244
Ildiko GA, Gabriela M, Maria PI (2016) Romanian translation and cross-cultural adaptation of the SarQol Questionnaire. Acta Med Marisiensis 62:384–385
Geerinck A, Scheppers A, Beaudart C, Bruyère O, Vandenbussche W, Bautmans R et al (2018) Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact 18(4):463–472
Konstantynowicz J, Abramowicz P, Glinkowski W, Taranta E, Marcinowicz L, Dymitrowicz M et al (2018) Polish validation of the SarQoL®, a Quality of Life Questionnaire specific to sarcopenia. J Clin Med 7:323
Tsekoura M, Billis E, Gliatis J, Tsepis E, Matzaroglou C, Sakkas GK et al (2018) Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire. Disabil Rehabil. https://doi.org/10.1080/09638288.2018.1514076
Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42
Tavakol M, Dennick R (2011) Making sense of Cronbach’s alpha. Int J Med Educ 2:53–55
Acknowledgements
The authors express their gratitude to Dr. Elvyra Stapcinskiene, Edita Merkeliuniene and Audrone Misiunaite for their assistance in the data collection.
Author information
Authors and Affiliations
Contributions
CB, OB, JYR, VA and MT were involved in the design of the study. JK and AM managed the study and performed statistical analysis. JK, AM, and MT drafted the manuscript. VA, MT, AG, CB, OB, and JYR made critical revision of the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethics statement and informed consent
Study protocol has been approved by Lithuanian regional biomedical research ethics committee. All subjects gave their written informed consent prior to enrolment.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Alekna, V., Kilaite, J., Tamulaitiene, M. et al. Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®). Eur Geriatr Med 10, 761–767 (2019). https://doi.org/10.1007/s41999-019-00208-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-019-00208-x